Please assess the completion status of the following clinical trial:

Trial Title: Alopecia Secondary to Endocrine Therapy in Postmenopausal Women With Breast Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: CROSS_SECTIONAL
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Postmenopausal women~* Diagnosed with hormone-receptor positive breast cancer~* Commenced adjuvant endocrine therapy ≥ 3 months ago, specifically Tamoxifen, Anastrozole, Exemestane, and/or Letrozole~* Good command of the English language~* Under the care of a medical oncologist at Princess Margaret Hospital~Exclusion Criteria:~* Previously received chemotherapy~* Recurrent and/or metastatic disease~* History of endocrine, dermatology, or immune system disorders known to alter hair growth (ie. Hypothyroidism and iron deficiency)

- Gender: FEMALE
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Postmenopausal Women on Endocrine Therapy (Type: None): Postmenopausal women with Breast Cancer that undergo Endocrine Therapy.

Based on this trial design, predict the completion outcome and termination type (if applicable).